A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants

Clinical Trial ID NCT01495260

PubWeight™ 1.68‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01495260

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol 2011 1.31
2 Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. Brain 2012 0.92
3 Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 2011 0.90
4 Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol 2016 0.79
Next 100